BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24124149)

  • 21. Waldenström macroglobulinemia caused by extranodal marginal zone B-cell lymphoma: a report of six cases.
    Valdez R; Finn WG; Ross CW; Singleton TP; Tworek JA; Schnitzer B
    Am J Clin Pathol; 2001 Nov; 116(5):683-90. PubMed ID: 11710684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small lymphocytic lymphoma with perifollicular, marginal zone, or interfollicular distribution.
    Gupta D; Lim MS; Medeiros LJ; Elenitoba-Johnson KS
    Mod Pathol; 2000 Nov; 13(11):1161-6. PubMed ID: 11106071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of MNDA as a new marker for nodal marginal zone lymphoma.
    Kanellis G; Roncador G; Arribas A; Mollejo M; Montes-Moreno S; Maestre L; Campos-Martin Y; Ríos Gonzalez JL; Martinez-Torrecuadrada JL; Sanchez-Verde L; Pajares R; Cigudosa JC; Martin MC; Piris MA
    Leukemia; 2009 Oct; 23(10):1847-57. PubMed ID: 19474799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination.
    Arcaini L; Burcheri S; Rossi A; Passamonti F; Paulli M; Boveri E; Brusamolino E; Orlandi E; Molteni A; Pulsoni A; Cox MC; Orsucci L; Fabbri A; Frezzato M; Voso MT; Zaja F; Montanari F; Pascutto C; Morra E; Cortelazzo S; Lazzarino M
    Oncologist; 2006 Mar; 11(3):285-91. PubMed ID: 16549813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD5-positive follicular lymphoma: prognostic significance of this aberrant marker?
    Mayson E; Saverimuttu J; Cartwright K
    Intern Med J; 2014 Apr; 44(4):417-22. PubMed ID: 24754692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marginal zone variant of mantle cell lymphoma: CD5-negative cyclin D1-positive variant posing a diagnostic dilemma.
    Golardi N; Velasco MR; Elghetany MT
    Pathol Int; 2009 May; 59(5):317-21. PubMed ID: 19432674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
    Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
    Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases.
    Salama ME; Lossos IS; Warnke RA; Natkunam Y
    Am J Clin Pathol; 2009 Jul; 132(1):39-49. PubMed ID: 19864232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperplasia of mantle/marginal zone B cells with clear cytoplasm in peripheral lymph nodes. A clinicopathologic study of 35 cases.
    Hunt JP; Chan JA; Samoszuk M; Brynes RK; Hernandez AM; Bass R; Weisenburger DD; Müller-Hermelink K; Nathwani BN
    Am J Clin Pathol; 2001 Oct; 116(4):550-9. PubMed ID: 11601140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias.
    Goldaniga M; Ferrario A; Cortelazzo S; Guffanti A; Pavone E; Ambrosetti A; Marcheselli L; Rossi F; Luminari S; Rossi A; Cro L; Federico M; Lambertenghi Deliliers G; Baldini L
    Am J Hematol; 2008 May; 83(5):349-54. PubMed ID: 18186522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma.
    Viswanatha DS; Foucar K; Berry BR; Gascoyne RD; Evans HL; Leith CP
    Mod Pathol; 2000 Jul; 13(7):825-33. PubMed ID: 10912944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical features of patients with nodal marginal zone lymphoma compared to follicular lymphoma: similar presentation, but differences in prognostic factors and rate of transformation.
    van den Brand M; van der Velden WJ; Diets IJ; Ector GI; de Haan AF; Stevens WB; Hebeda KM; Groenen PJ; van Krieken HJ
    Leuk Lymphoma; 2016 Jul; 57(7):1649-56. PubMed ID: 26694256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma.
    Hyo R; Tomita N; Takeuchi K; Aoshima T; Fujita A; Kuwabara H; Hashimoto C; Takemura S; Taguchi J; Sakai R; Fujita H; Fujisawa S; Ogawa K; Motomura S; Suzuki R; Ishigatsubo Y
    Hematol Oncol; 2010 Mar; 28(1):27-32. PubMed ID: 19358143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-MALT marginal zone lymphoma.
    Thieblemont C; Davi F; Noguera ME; Brière J
    Curr Opin Hematol; 2011 Jul; 18(4):273-9. PubMed ID: 21577105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nodal marginal zone lymphoma.
    Angelopoulou MK; Kalpadakis C; Pangalis GA; Kyrtsonis MC; Vassilakopoulos TP
    Leuk Lymphoma; 2014 Jun; 55(6):1240-50. PubMed ID: 24004184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative analysis of cutaneous marginal zone lymphoma and cutaneous chronic lymphocytic leukemia.
    Levin C; Mirzamani N; Zwerner J; Kim Y; Schwartz EJ; Sundram U
    Am J Dermatopathol; 2012 Feb; 34(1):18-23. PubMed ID: 22257836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric nodal marginal zone lymphoma may develop in the adult population.
    Gitelson E; Al-Saleem T; Robu V; Millenson MM; Smith MR
    Leuk Lymphoma; 2010 Jan; 51(1):89-94. PubMed ID: 19863176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B-cell lymphoma with hyaline vascular Castleman disease-like features: a clinicopathologic study.
    Siddiqi IN; Brynes RK; Wang E
    Am J Clin Pathol; 2011 Jun; 135(6):901-14. PubMed ID: 21571963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of CD5-positive splenic marginal zone lymphoma with leukemic manifestation ; clinical, flow cytometry, and histopathological findings of 11 cases.
    Kojima M; Sato E; Oshimi K; Murase T; Koike T; Tsunoda S; Matsumoto T; Marutsuka K; Ogiya D; Moriuchi M; Tokunaka M; Yara Kikuti Y; Kikuchi T; Nakamura N; Ando K
    J Clin Exp Hematop; 2010; 50(2):107-12. PubMed ID: 21123968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias.
    Cro L; Guffanti A; Colombi M; Cesana B; Grimoldi MG; Patriarca C; Goldaniga M; Neri A; Intini D; Cortelezzi A; Maiolo AT; Baldini L
    Leukemia; 2003 Jan; 17(1):125-32. PubMed ID: 12529669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.